ERBB4 and breast cancer: To experimentally address this, estrogen-dependent ER-positive human MCF-7 breast cancer cells were treated for 24 hours with 10 nM estradiol and the amount of ErbB4 ectodomain accumulating in the conditioned medium was measured by Western blotting.